News
GSK plc (NYSE:GSK) is one of the 11 best European stocks to invest in. On June 24, the company announced receipt of FDA ...
Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop ...
The U.S. Food & Drug Administration (FDA) has granted approval for a new subcutaneous autoinjector formulation of belimumab ...
Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop it in its tracks. By Nina Agrawal Jennifer Le’s doctor ticked ...
The Lupus Foundation of Arkansas is set to host its eighth annual talent show on June 28 at the Little Rock Southwest High ...
Researchers from EMD Serono and global collaborators shared promising results from Cohort B of the phase II trial of the WILLOW study.
The American College of Rheumatology has updated its systemic lupus erythematosus treatment guidelines for the first time ...
The U.S. Food and Drug Administration has approved GSK's autoinjector of Benlysta (belimumab) for subcutaneous injection in ...
Dysregulation of the alternative complement pathway, hallmarked by isolated reduction of the serum C3 fraction, is now recognized as an additional feature of lupus nephritis. Persistent, isolated low ...
BlackDoctor Foundation & AstraZeneca unite to fight cancer & lupus. Hear inspiring survivor stories and learn about early ...
Over 300 attendees raised $450,000 to fuel research breakthroughs for those living with lupus SUMMIT, N.J., June 24, 2025 ...
New research by Swansea University and Cambridge University has revealed the causes and devastating impacts of delays—that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results